2024-519834-21-00CompletedPhase 1
A trial to learn if itraconazole and carbamazepine affect how AZD5462 moves throughout the bodies of healthy adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Apr 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- First submitted
- 14 Feb 2025
- Start date
- 6 May 2025
- Lead sponsor
- AstraZeneca AB
- EU CT number
- 2024-519834-21-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 42
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Parexel International GmbH | Berlin | Germany | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.